Skip to main content

Advertisement

Figure 7 | Microbial Cell Factories

Figure 7

From: Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy

Figure 7

Dot blot assay indicating the IgE reactivity of rSbpA/Bet v1 fusion protein. Results indicated that rSbpA/Bet v1 (B) and rBet v1 (A) which was used as a positive control showed strong IgE reactivity when incubated with Bet v1-specific serum samples of birch pollen allergic patients. Recombinant SbpA (C) used as a blank did not show any reactivity.

Back to article page